Accelerated Fetal Growth in Early Pregnancy and Risk of Preterm Birth: A Prospective Cohort Study



Background: Preterm birth (occurring before 37 completed weeks of gestation) affects 15 million infants annually, 7.5% of which die due to related complications. The detection and early diagnosis are therefore paramount in order to prevent the development of prematurity and its consequences. So far, focus has been laid on the association between reduced intrauterine fetal growth during late gestation and prematurity. The aim of the current study was to investigate the association between accelerated fetal growth in early pregnancy and the risk of preterm birth.

Methods: This prospective cohort study included 69 617 singleton pregnancies without congenital malformations and with available biometric measurements during the first and second trimester. Estimation of fetal growth was based on measurements of biparietal diameter (BPD) at first and second trimester scan. We investigated the association between accelerated fetal growth and preterm birth prior to 37 weeks of gestation. The outcome was further stratified into very preterm birth (before 32 weeks of gestation) or moderate preterm birth (between 32 and 37 weeks of gestation) and medically induced or spontaneous preterm birth and was further explored.

Results: The odds of prematurity were increased among fetuses with accelerated BPD growth (> 90th centile) estimated between first and second ultrasound scan, even after adjustment for possible confounders (aOR 1.36; 95% CI 1.20-1.54). The findings remained significant what regards moderate preterm births but not earlier births. Regarding medically induced preterm birth, the odds were found to be elevated in the group of fetuses with accelerated growth in early pregnancy (aOR 1.34; 95% CI 1.11-1.63). On the contrary, fetuses with delayed fetal growth exhibited lower risk for both overall and spontaneous preterm birth.

Conclusions: Fetuses with accelerated BPD growth in early pregnancy, detected by ultrasound examination during the second trimester, exhibited increased risk of being born preterm. The findings of the current study suggest that fetal growth in early pregnancy should be taken into account when assessing the likelihood for preterm birth.


Preterm delivery, i.e., birth prior to 37 gestational weeks, complicates 4–13% of deliveries worldwide and is the predominant cause of neonatal morbidity and mortality, having an impact on approximately 15 million infants annually. (13) Preterm born infants have a higher risk for adverse outcomes primarily during the neonatal period; however, harmful effects have been described to extend even at later life stages, leading to attention deficit disorders and learning impairment in childhood. (4, 5)

Previous research has described that the etiology and timing of preterm birth is multifactorial and several projects have focused on fetal growth, usually attempting to detect fetuses at increased risk of growth restriction. In contrast, only few reports have described the effect of increased fetal size at birth and spontaneous preterm onset of labor; in a population-based, as well as a hospital-based registry study performed in Sweden and Canada respectively, the authors demonstrated an increased risk for prematurity among fetuses with birthweight exceeding the expected.(6, 7)

Despite the previous presumption that biological variation in fetal growth is minimal in early pregnancy and that abnormal fetal growth manifests at a later stage, there have been a number of studies showing the impact of fetal growth during early gestation on adverse pregnancy outcomes. (811) However, only few of them focused on accelerated fetal growth patterns among pregnancies with preterm birth. Lampl et al. followed fetal growth in 3 927 pregnancies from gestational week 16 up to spontaneous birth and observed an increased risk for prematurity among fetuses with accelerated growth in the second trimester. (11) Pedersen et al. investigated fetal growth in 8 215 early singleton pregnancies and reported an increased risk of preterm birth among fetuses with accelerated fetal growth, with results almost reaching statistical significance. (10) Hence, in order to overcome possible statistical challenges and enhance clinical relevance, we decided to perform a study with serial ultrasound measurements in a large, low risk obstetric population.

The primary aim of the present study was to investigate whether accelerated fetal growth, as assessed by BPD measurements, in the first half of pregnancy influenced the risk of preterm birth overall. The secondary aims were to further explore whether fetal growth differed between i) moderate and very preterm birth, as well as ii) spontaneous and medically induced preterm birth.


Study design and population

The study design is that of a longitudinal cohort study with prospectively collected data originating from a population-based obstetric database. The information gathered regard data on maternal, delivery and infant characteristics from all antenatal, ultrasound, delivery, and postnatal care units in the counties of Stockholm and Gotland in Sweden. Information about maternal reproductive history, lifestyle habits, height, weight, and state of health are usually recorded by midwives at the first antenatal visit and during pregnancy. Biometric measurements used in the study were collected from all ultrasound units in the region, and information about pre-gestational maternal diabetes and chronic hypertension, was obtained from standard delivery charts as well as diagnoses at discharge from the delivery hospital.

Singleton pregnancies (72 309) from the population area of the study with available data on biometric measurements in the first and early second trimester between January 1st, 2008 and October 22nd, 2014 were included in the study sample. Pregnancies with congenital malformations (n= 2 495) [International Classification of Diseases tenth revision (ICD-10) codes Q00-Q99)] or stillbirths (n=197) were excluded, resulting in a final study population of 69 617 singleton pregnancies.


The study exposure regarded differences in fetal biometric parameters, such as the biparietal diameter (BPD), measured by ultrasound scan during the first half of pregnancy. The Swedish Association for Obstetrics and Gynecology (SFOG) dictates that fetal BPD should be measured from the outer edge of the proximal parietal bone to the inner edge of the distal parietal bone at the level of thalami and septum pellucidum and performed by specially trained midwives according to a standardized protocol (8). Firstly, we estimated gestational age based on biometrical measurements obtained at first trimester ultrasound scan (i.e. the combined ultrasound and biochemical screening test, CUB). Next, we related the observed fetal size at the second scan to the expected size estimated on the basis of the first trimester scan. At both first trimester (11+0 to 13+6 weeks of gestation) and second trimester (14+0 to 21+0 weeks of gestation) ultrasound examinations, gestational age was extrapolated from the formula by Selbing (gestational age= 58.65 + 1.07 x BPD + 0.0138 x ((BPD)2).  Expected gestational age at second trimester scan was calculated by adding number of days between the two examinations to the observed gestational age at first trimester scan. The difference between observed and expected gestational age at second trimester scan, was expressed in z scores (z = , where μ equals the mean and σ equals the standard deviation). The individual z scores were transformed into centiles and fetuses with growth more than the 90th percentile were defined as having accelerated growth, while fetuses with growth between the 10th and 90th percentile were considered as appropriate and used as the reference group. Fetuses with growth smaller than expected (<10th percentile) were considered to be of delayed growth.


The outcome measure was overall prematurity (i.e. birth at < 37+0 weeks). Furthermore, we analyzed the risk for very preterm birth (birth at <32+0 weeks) and moderate preterm birth (birth between 32+0 and 37+0 weeks).  Preterm births with clinician-initiated obstetric interventions, as opposed to spontaneous preterm births, were defined as medically induced preterm births and included prelabor C-sections and induced labors.


Pregnancy characteristics collected from the woman’s medical records regarded maternal age at first antenatal visit (< or ≥35 years), maternal height (< or ≥ 155 cm), BMI at early pregnancy (< or ≥ 30 kg/m2), primiparity (yes/no), smoking at early pregnancy (yes/no), use of in vitro fertilization (IVF) for the current pregnancy (yes/no), pre-gestational diabetes mellitus (yes/no), chronic hypertension (yes/no) and male fetal gender (yes/no). Pre-pregnancy diabetes mellitus was defined by the ICD-10 diagnosis codes O240, O241, while chronic hypertension was defined as treatment with antihypertensive medication at first antenatal visit and/or ICD-10 diagnosis code indicating chronic hypertension (O10, O11) developed at any time point before the 20th gestational week. ICD codes were provided by the responsible doctor at discharge from the hospital after delivery, while information regarding blood pressure measurements, proteinuria, and medication was provided by midwives at antenatal care or at the hospital before delivery. Information on fetal gender was collected from delivery charts. Maternal country of birth was divided into Sweden, other Nordic countries (i.e., Norway, Denmark, Finland, and Iceland), and non-Nordic countries. Information on paternal characteristics was not available in the database.

Data analysis

The statistical software package SAS 9.4 (version 6.1; SAS, Cary, NC, USA) was used for the statistical analyses and a two-sided p-value below 0.05 was considered statistically significant. Pregnancy characteristics in categorical form were cross-tabulated with both exposure and outcome and compared with the use of chi square test.  Risk for accelerated growth (>90th percentile) or delayed growth (<10th percentile) was calculated based on discrepancy in fetal growth at early second trimester scan, using fetuses with appropriate growth (10th to 90th percentile) as the reference group. The risk of preterm birth was estimated by multivariable unconditional logistic regression analysis and expressed as crude and adjusted odds ratios (aORs) with 95% confidence intervals (CIs).  Adjustments were made for maternal age (< or ≥ 35 years), maternal height (< or ≥ 155 cm), BMI (< or ≥ 30 kg/m2), non-Nordic origin (yes/no), primiparity (yes/no), smoking (yes/no), IVF (yes/no), pre-gestational diabetes mellitus (yes/no), chronic hypertension (yes/no) and male fetal gender. The selection of potential confounders recorded at the first antenatal visit, was based on directed acyclic graphs (DAGs) (Figure S1).

Ethical approval

The study was approved by the Regional Ethical Review Authority in Stockholm, Sweden (Dnr 2014/2179-31/1). The need for written or oral informed consent for participation in the study was weaved since all collected data were depersonalized prior to the analysis.

Patient and public involvement

There was no patient or public involvement in the design, conduct, reporting or dissemination plans of our research study.


The characteristics of the study population according to gestational age at birth are presented in Table 1. Overall, 2 838 (4%) of all pregnancies ended preterm; 2 460 (3.5%) pregnancies ended between 32 and 37 weeks of gestation while 0.5% ended before 32 weeks of gestation. More specifically, 40.6% of overall preterm deliveries were initiated by clinicians (medically induced) and 59.4% started spontaneously. Mothers delivering preterm were more often pregnant through IVF, born outside the Nordic countries, were multiparous, overweight or obese, of short height or were treated for chronic hypertension.

Based on the information on biometric measurements, 7 091 (10.1 %) of fetuses had BPD growth more than the 90th percentile at the second trimester ultrasonic scans. In 55 571 (79.8 %) of fetuses, the growth was between 10th and 90th percentile, while 10.1 % of fetuses had a BPD growth smaller than expected (< 10th percentile). Mothers whose fetus had exhibited accelerated fetal growth at second trimester were more often younger and multiparous compared to those whose fetus had appropriate fetal growth. Male fetuses at second trimester were more often larger in size than female fetuses (Table 2). 

Compared to fetuses with appropriate growth at early second trimester ultrasound, fetuses with accelerated growth had a 40 % increased likelihood for prematurity, both what regards moderate as well as very preterm birth. The association between fetal growth and overall and moderate preterm birth remained unchanged despite adjusting for maternal characteristics, pre-pregnancy diabetes, chronic hypertension and fetal gender (Table 3). However, the likelihood for very preterm birth did not reach statistical significance after adjustment.

Medically induced labor was observed in 40.6 % of preterm births with the odds of prematurity being increased among fetuses with accelerated growth compared to fetuses with appropriate growth at second trimester scan. Even after adjustment for relevant confounders, the risks remained elevated (Table 4). 

On the other hand, 6 955 fetuses were smaller than expected at second trimester scan (growth less than 10th percentile). Among them, 234 fetuses were born preterm (31 were born very preterm and 203 moderate preterm). Fetuses that experienced delayed growth in early pregnancy, had a decreased likelihood for preterm birth (aOR 0.84; 95% CI 0.71-0.97), an effect seen mostly among spontaneously preterm born infants (Table 3 and 4).


In this registry-based study, we have demonstrated that early accelerated fetal growth, reflected by an increase in BPD measurement estimated by ultrasound, was associated with an increased risk of preterm birth. The effect estimates remained unchanged even after stratification according to timing, as well as to type of preterm birth (i.e. very preterm vs moderate preterm birth and medically induced vs spontaneous preterm birth). These findings underline the importance of early fetal growth and the potential association to complications later in pregnancy.

In accordance with our study, Pedersen et al. demonstrated an increased risk for prematurity among fetuses with accelerated growth; OR 3.27 (95% CI, 0.99-10.73) for very preterm births 22-33 weeks and OR 2.30 (95 % CI, 1.15-4.59) for moderate preterm births. (10) Similarly to our study, their population included a relatively small number of pregnant women suffering from very preterm birth, which could partly explain why the results did not reach statistical significance (p=0.074). (10) Additionally, the association between increased birthweight and elevated risk of preterm birth has been previously described, but without focus on growth in early pregnancy.(6, 7) In the cohort of one million births recorded in the Swedish Medical Birth Register, Morken et al. observed increased risk for birth between 34 and 36 weeks of gestation (OR 1.6, 95% CI 1.5-1.7) among infants with larger birthweight than the population mean. (7) Similarly, Gaillard et al, observed an increased risk for overall and spontaneous preterm birth among fetuses with larger head circumference in second trimester. (12) On the contrary, in the study performed by Partap et al., the authors observed an inverse relationship between growth velocity of femur length in second trimester and risk of spontaneous preterm birth.(13) An unexpected finding of our study was the decreased risk for prematurity observed among fetuses that had smaller than expected BPD at the ultrasound scan of the second trimester. Despite adjusting for chronic hypertension, preeclampsia and other potential risk factors for medically induced prematurity, the risk of prematurity for fetuses with delayed growth remained nevertheless lower compared to the reference group (i.e., fetuses with normal growth).

The incidence of preterm birth estimated in our study is in accordance with the reported national rates in Sweden and other Nordic countries. (7, 14, 15) However, in our study, 40.6% of preterm births were classified as medically initiated births, compared to 35% and 25% reported in previous Swedish studies. (7, 14) These variations could be the result of methodological differences in study design such as different cut-offs of preterm birth employed, or different outcome definitions such as that of premature preterm rupture of membranes (pPROM). (7, 14) Furthermore, the higher rates of medically induced preterm births observed in our study could reflect increasing rates of medical intervention over time, a trend that has also been reported in other settings. (15-18)

Although the exact pathophysiological mechanism behind our findings still remains unknown, a number of possible hypotheses associated to the onset of labor have been proposed. One of the theories to explain the timing of birth refers to prelabor mechanical distention and stretching of the myometrium. The overdistention of the uterus leads to increased expression of contraction-associated proteins (such as connexin-43), and initiate the necessary biochemical steps towards coordinated and forceful contractions. (19) (20) (21) Based on the physiology of uterine contractions, it is thus reasonable to assume that accelerated fetal growth could increase the distension demands posed on the uterus to a greater degree than during normal fetal growth and subsequently trigger spontaneous preterm labor. The theory is also in line with the contrasting finding of preterm birth and delayed fetal growth. One can only assume that fetuses smaller than expected, do not grow at the same velocity and probably do not reach equally large birthweights as fetuses with accelerated growth, decreasing thereby the risk of triggering or activating the labor system at a preterm stage.

One of the major strengths of our study is the accurate estimation of gestational age based on ultrasonographic measurements at the first trimester of pregnancy and not on the self-reported last menstrual period of the participating women which can often be unreliable. Furthermore, we attempted to explore growth velocity based on the measurements of only one biometric characteristic (i.e., BPD), since it was the only biophysical parameter that was readily available both at first and second trimester scan. The latter, in addition to the possibility of calculating gestational age solely based on BPD measurements also justifies why the formula by Selbing was employed, enabling us at the same time to avoid uncertainty introduced by utilizing different calculation methods. Another major strength lies on the large sample size with detailed information collected prospectively, which limits the risk for recall bias. The large cohort size in the study, made it possible to stratify the analysis in spontaneous and medically induced groups, as well as in moderately preterm and very preterm groups and therefore explore rare outcomes. Furthermore, Sweden has a long tradition of valid registries entailing routinely collected, comprehensive and accurate data especially in the perinatal field. In addition, the publicly funded healthcare system of the country enables equal access to prenatal healthcare and early identification and possibly preventive intervention against preterm birth. That makes Sweden an appropriate model country to explore the research question. Lastly, since all ultrasound units in Sweden follow the same professional standards, we can only assume that the performance variation of the ultrasound examiners is restricted. (8)

The present study is however not void of limitations. First and foremost, we lack information on the paternal characteristics, which along with the maternal might influence fetal growth. Furthermore, as we were obliged to restrict our population to pregnancies where CUB was performed and a fraction of the population did not perform first trimester sonographic scans, a potential selection bias related to advanced maternal age cannot entirely be ruled out. We have therefore tried to account for it by adjusting for advanced maternal age in the logistic regression analysis. However, despite the fact that the CUB scan is optional in Sweden, many women choose nevertheless to undergo ultrasound examination both in the first and second trimester making our results applicable in the clinical setting. There is of course the risk that fetal growth velocity was already affected at the time of the dating of the pregnancy (gestational week 11-14), on which the calculation of gestational age was based. By including in the performed risk analyses detailed information on maternal, pregnancy and fetal characteristics, known to affect both first-trimester growth and the risk of preterm birth (22-27) that scenario was accounted for. Finally, our population comes mainly from the urban area of the capital of Sweden (Stockholm) and its composition corresponds to that of other large cities, potentially affecting the generalizability of our findings in the wider birthing population. 


Accelerated fetal growth during early gestation is associated with an increased risk of preterm birth overall, as well as with medically induced and spontaneous preterm birth. There is currently no recommendation on the management of pregnancies with accelerated fetal growth early in pregnancy. Identification of pregnancies at risk could allow proper interventions such as counselling on maternal nutrition and physical activity or even introduction of more appropriate surveillance considering the risk for prematurity. Further research on the topic is therefore warranted.


ICD International Statistical Classification of diseases–10th edition

BPD Biparietal diameter

OR Odds ratio

CI Confidence interval

BMI Body mass index

IVF In vitro fertilization

CUB Combined ultrasound and biochemical screening test


Ethics approval and consent to participate

The study was approved by the Regional Ethical Review Authority in Stockholm, Sweden (Dnr 2014/2179-31/1). The need for written or oral informed consent for participation in the study was weaved since all collected data were depersonalized prior to the analysis.

Consent for publication

Not applicable.

Availability of data and materials

The datasets generated and analysed during the current study are not publicly available and cannot be uploaded at any website due to the risk of compromising the individual privacy of participants. On the other hand, the data is available from the responsible department upon reasonable request. Any interested parties are welcome to contact the authors, who will then fill out the agreements necessary when sharing data and after approval by the Regional Ethics Board in Stockholm, Sweden. All data regarding the current study are available on request to the Department of Women's and Children's Health, Karolinska Institutet.

Competing interests: EE has received lecture fee from Gideon Richter outside the submitted work. The other authors have no conflicts of interest to declare.


The authors received no specific funding for this work. EE has a part-time research position funded by Uppsala University Hospital (grant no. ALF 1040530/2019). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Authors’ contributions

MS has been responsible for the design of the study and data collection. MS and EE have equally contributed in data analysis, the interpretation of the results and drafting of the manuscript. AKW has assisted in drafting the manuscript and has critically revised it. All authors have approved the final version submitted.


Not applicable.


  1. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027–35.
  2. Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S, et al. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet. 2013;381(9862):223–34.
  3. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10(Suppl 1):2.
  4. Lawn JE, Cousens S, Zupan J. Lancet Neonatal Survival Steering T. 4 million neonatal deaths: when? Where? Why? Lancet. 2005;365(9462):891–900.
  5. Petrini JR, Dias T, McCormick MC, Massolo ML, Green NS, Escobar GJ. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 2009;154(2):169–76.
  6. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. American journal of obstetrics gynecology. 2001;184(5):946–53.
  7. Morken NH, Kallen K, Jacobsson B. Fetal growth and onset of delivery: a nationwide population-based study of preterm infants. American journal of obstetrics gynecology. 2006;195(1):154–61.
  8. Simic M, Wikstrom AK, Stephansson O. Accelerated fetal growth in early pregnancy and risk of severe large-for-gestational-age and macrosomic infant: a cohort study in a low-risk population. Acta obstetricia et gynecologica Scandinavica. 2017;96(10):1261–8.
  9. Mook-Kanamori DO, Steegers EA, Eilers PH, Raat H, Hofman A, Jaddoe VW. Risk factors and outcomes associated with first-trimester fetal growth restriction. JAMA. 2010;303(6):527–34.
  10. Pedersen NG, Wojdemann KR, Scheike T, Tabor A. Fetal growth between the first and second trimesters and the risk of adverse pregnancy outcome. Ultrasound in obstetrics gynecology: the official journal of the International Society of Ultrasound in Obstetrics Gynecology. 2008;32(2):147–54.
  11. Lampl M, Kusanovic JP, Erez O, Espinoza J, Gotsch F, Goncalves L, et al. Early rapid growth, early birth: accelerated fetal growth and spontaneous late preterm birth. Am J Hum Biol. 2009;21(2):141–50.
  12. Gaillard R, Steegers EA, de Jongste JC, Hofman A, Jaddoe VW. Tracking of fetal growth characteristics during different trimesters and the risks of adverse birth outcomes. Int J Epidemiol. 2014;43(4):1140–53.
  13. Partap U, Sovio U, Smith GC. Fetal Growth and the Risk of Spontaneous Preterm Birth in a Prospective Cohort Study of Nulliparous Women. Am J Epidemiol. 2016;184(2):110–9.
  14. Murray SR, Juodakis J, Bacelis J, Sand A, Norman JE, Sengpiel V, et al. Geographical differences in preterm delivery rates in Sweden: A population-based cohort study. Acta obstetricia et gynecologica Scandinavica. 2019;98(1):106–16.
  15. Richards JL, Kramer MS, Deb-Rinker P, Rouleau J, Mortensen L, Gissler M, et al. Temporal Trends in Late Preterm and Early Term Birth Rates in 6 High-Income Countries in North America and Europe and Association With Clinician-Initiated Obstetric Interventions. JAMA. 2016;316(4):410–9.
  16. Richter LL, Ting J, Muraca GM, Synnes A, Lim KI, Lisonkova S. Temporal trends in neonatal mortality and morbidity following spontaneous and clinician-initiated preterm birth in Washington State, USA: a population-based study. BMJ Open. 2019;9(1):e023004.
  17. Stout MJ, Demaree D, Merfeld E, Tuuli MG, Wambach JA, Cole FS, et al. Neonatal Outcomes Differ after Spontaneous and Indicated Preterm Birth. Am J Perinatol. 2018;35(5):494–502.
  18. Wong AE, Grobman WA. Medically indicated–iatrogenic prematurity. Clin Perinatol. 2011;38(3):423–39.
  19. Garfield RE, Kannan MS, Daniel EE. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol. 1980;238(3):C81-9.
  20. Terzidou V, Sooranna SR, Kim LU, Thornton S, Bennett PR, Johnson MR. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab. 2005;90(1):237–46.
  21. Maradny EE, Kanayama N, Halim A, Maehara K, Terao T. Stretching of fetal membranes increases the concentration of interleukin-8 and collagenase activity. American journal of obstetrics gynecology. 1996;174(3):843–9.
  22. Peelen MJ, Kazemier BM, Ravelli AC, De Groot CJ, Van Der Post JA, Mol BW, et al. Impact of fetal gender on the risk of preterm birth, a national cohort study. Acta obstetricia et gynecologica Scandinavica. 2016;95(9):1034–41.
  23. Ion RC, Wills AK, Bernal AL. Environmental Tobacco Smoke Exposure in Pregnancy is Associated With Earlier Delivery and Reduced Birth Weight. Reprod Sci. 2015;22(12):1603–11.
  24. Waldenstrom U, Cnattingius S, Vixner L, Norman M. Advanced maternal age increases the risk of very preterm birth, irrespective of parity: a population-based register study. BJOG. 2017;124(8):1235–44.
  25. Van Leeuw V, Leroy C, Englert Y, Zhang WH. Effect of maternal origin on the association between maternal height and risk of preterm birth in Belgium: a retrospective observational cohort study. BMJ Open. 2018;8(4):e020449.
  26. Kim SS, Mendola P, Zhu Y, Hwang BS, Grantz KL. Spontaneous and indicated preterm delivery risk is increased among overweight and obese women without prepregnancy chronic disease. BJOG. 2017;124(11):1708–16.
  27. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
  28. Legends to Supporting Information.


  1. Baseline characteristics of mothers according to gestational age at birth. (N= 69 617 births).


Very preterm births a


Moderate preterm births b

(n=2 460)

Term birthsc

(n= 62 971)

Postterm births d

(n=3 808)

P- value

Maternal age older than 35 y

197 (52.1)

1 121 (45.6)

28 470 (45.2)

1 789 (46.9)


Short maternal height (< 155 cm)

17 (4.5)

98 (3.9)

1 508 (2.4)

57 (1.5)


Obesity (BMI ≥ 30 kg/m2)

40 (10.9)

219 (9.4)

4 055 (6.7)

271 (7.5)


Non- Nordic origin

88 (25.8)

413 (19.6)

10 312 (18.4)

525 (15.9)



182 (48.1)

1 187 (48.2)

36 197 (57.5)

1 629 (42.8)



15 (4.1)

82 (3.4)

1 575 (2.5)

82 (2.2)


In vitro fertilization (IVF)

45 (11.9)

228 (9.3)

3 993 (6.3)

168 (4.4)


Chronic hypertension

11 (2.9)

51 (2.1)

556 (0.9)

27 (0.7)


Pre-gestational diabetes mellitus

1 (0.2)

28 (1.1)

116 (0.2)



Male fetal gender

208 (55.0)

1 334 (54.2)

31 959 (50.7)

2 028 (53.3)





a Very preterm birth: gestational age less than 32 weeks.

b Moderate preterm birth: gestational age between 32+0 and 36+6.

c Term birth: gestational age between 37+0 and 41+6.

d Postterm birth: gestational age 42 weeks or more.

Table 2. Baseline characteristics for mothers according to fetal growth in early pregnancy. (N=69 617 births)





Accelerated fetal growth a

(n= 6 955)

Appropriate fetal growth b

(n= 55 571)

Delayed fetal growth c

(n=7 091)

P- value

Maternal age older than 35 y

3 117 (43.9)

25 108 (45.2)

3 352 (47.2)


Short maternal height

(< 155cm)

143 (2.0)

1 367 (2.4)

170 (2.4)


Obesity (BMI ≥30 kg/m2)

440 (6.5)

3 658 (6.9)

487 (6.8)


Non- Nordic origin

1 092 (17.7)

9 043 (18.4)

1 203 (16.9)



3 409 (48.1)

31 269 (56.3)

4 517 (63.7)



177 (2.5)

1 538 (2.5)

210 (2.9)


In vitro fertilization (IVF)

443 (6.2)

3 649 (6.5)

342 (4.8)


Chronic hypertension

62 (0.8)

523 (0.9)

60 (0.8)


Pre-gestational diabetes mellitus

12 (0.2)

116 (0.2)

17 (0.2)


Male fetal gender

4 988 (70.4)

28 179 (50.7)

2 362 (33.9)


a Accelerated fetal growth at second trimester scan was defined as BPD measurement at the 90th percentile, or more of the expected for gestational age.

b Appropriate fetal growth at second trimester scan was defined as BPD measurement between 10th – 90th percentile of the expected for gestational age.

c  Delayed fetal growth at second trimester scan was defined as BPD measurement at the 10th percentile, or less of the expected for gestational age.




Growth at second trim scan

     All preterm births

(n=2 838)

Very preterm births


Moderate preterm births

(n=2 460)


No. of women


Odds ratio (95% CI)


No. of women


Odds ratio (95% CI)


No. of women


Odds ratio (95% CI)


Adjusted *


Adjusted *



Adjusted *


Accelerated fetal growtha


























Appropriate fetal growthb


2 215












1 920






Delayed fetal growthc


































  1. Growth in early pregnancy and risk of preterm birth, very preterm and moderate preterm birth. (N=2 838 births).


*Adjusted OR for maternal age older than 35 yrs., short maternal height < 155 cm, BMI ≥ 30 kg/m2, non-Nordic origin, primiparity, smoking, IVF, pre-gestational diabetes mellitus, chronic hypertension and male fetal gender.


a Accelerated fetal growth at second trimester scan was defined as BPD measurement at the 90th percentile, or more of the expected for gestational age.

b Appropriate fetal growth at second trimester scan was defined as BPD measurement between 10th  -90th  percentile of the expected for gestational age.

c  Delayed fetal growth at second trimester scan was defined as BPD measurement at the 10th percentile, or less of the expected for gestational age 


  1. Growth in early pregnancy and risk of preterm birth either spontaneous or medically induced. (N= 2 838 births)





Growth at second trim scan

              Spontaneous preterm birth

                   (n=1 687)

Medically induced preterm birth

  (n=1 151)


No. of women


Odds ratio (95% CI)


No. of women


Odds ratio (95 % CI)


Adjusted *





Accelerated fetal growtha



















Appropriate fetal growthb




1 325


















Delayed fetal growthc


























*Adjusted OR for maternal age older than 35 yrs., short maternal height < 155 cm, BMI ≥ 30 kg/m2, non-Nordic origin, primiparity, smoking, IVF, chronic hypertension, pre-gestational diabetes mellitus and male fetal gender. 

a Accelerated fetal growth at second trimester scan was defined as BPD measurement at the 90th percentile, or more of the expected for gestational age.

b Appropriate fetal growth at second trimester scan was defined as BPD measurement between 10th - 90th percentile of the expected for gestational age.

c Delayed fetal growth at second trimester scan was defined as BPD measurement at the 10th percentile, or less of the expected for gestational age.